Method for detecting neoplastic disorders in a solubilized body sample

一种样本中、样本的技术，应用在检测癌症,的体外诊断装置,检测分子标记,抑制因子水平的检测试剂盒领域，能够解决没有公开LBC样本制备方法等问题

Active Publication Date: 2006-09-20
ROCHE MTM LAB AG
View PDF4 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Based on the disclosure of the prior literature in the field, there is no disclosure of the preparation method of the dissolved LBC sample for subsequent biochemical detection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting neoplastic disorders in a solubilized body sample

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0166] Example 1: Detecting cervical intraepithelial neoplasia by ELISA

[0167] Provided 33 cervical swabs present in the lysis medium, the cyclin-dependent kinase inhibitor p16 in the solution prepared from the cells contained in the swab was detected by an ELISA-based method INK4a The overexpression. The ELISA test is implemented as follows:

[0168] (A) Cell lysis

[0169] Put the cervical swab brush into a 15 ml container containing 2 ml of mtm lysis medium (2% Triton-X 100 in PBS, 0.4% SDS, 0.6 mM PMSF). Cervical cells present on the brush are lysed for at least 20 hours. Then transfer the lysate of the cervical swab sample into a 2ml test tube, and centrifuge at 4°C (28.000×g for 15 minutes (16.600rpm high-speed centrifuge JEC Multi RF)); transfer the supernatant to a new test tube. The supernatant can be stored at -20°C.

[0170] (B) Implement ELISA

[0171] Coated ELISA plate

[0172] Dilute p16 with PBS INK4a The specific antibody clones mtm E6H4 stock solution to a usab...

Embodiment 2

[0203] Example 2: Detection of intraepithelial neoplasia of the cervix by lateral flow detection

[0204] Perform routine PAP testing on 9 provided cervical swabs in PreservCyt (Cytyc Corporation, Boxborough, MA) solution, while using a lateral flow-based method to detect cyclin in a solution prepared from the cell suspension obtained from the swab Inhibitor of dependent kinase p16 INK4a The overexpression. The flow detection is implemented as follows:

[0205] (A) Cell lysis

[0206] From PreservCyt TMThe 10ml cell suspension of the individual's cervical swab sample provided by the fixed material was transferred into a 15ml reaction vessel. The sample was centrifuged at 1500×g at room temperature for 15 minutes (3000rpm, Heraeus Varifuge, rotor8074); the supernatant was discarded and the remaining methanol was allowed to evaporate (room temperature, 15 minutes); the precipitate was dissolved in 500μl of lysis buffer, and then transferred to 1.5 ml reaction solution container. The...

Embodiment 3

[0219] Example 3: Detection of p16 using RT-PCR method INK4a And p14 ARF Transcription of

[0220] Cervical samples from 50 individuals were used for this analysis. For each individual, obtain two samples, one in the Universal Collection Medium (Universal Collection Medium) and the other in the PreservCyt TM In solution. Two samples were obtained in the same testing process. For each individual, based on the data from PreservCyt TM Diagnosis is obtained by analysis of thin cervical specimens prepared in the solution. In this study, 20 samples were selected to be diagnosed as NILM, 20 samples were diagnosed as LSIL, and 10 samples were diagnosed as HSIL. According to the following method, using RT-PCR method to analyze the p16 of all samples at the mRNA level INK4a And p14 ARF The transcription level is determined:

[0221] To perform the analysis, cells were removed from UCM and PreservCyt by centrifugation TM Precipitation in solution. The obtained precipitate is directly subject...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a method for the early diagnosis of neoplastic disorders such as cancers as well as their precursor stages, particularly cancers of the respiratory tract, the urinary system, the reproductive tract, cancer associated with HPV infection or cancer of the anogenital tract, from solubilized body samples. The development of the kits and in-vitro diagnostic devices for the above purpose is also one aspect of the present invention.

Description

[0001] The present invention relates to a method for early diagnosis of tumors in a lysed body sample, such as cancer and its pre-conditions, particularly respiratory tract cancer, urinary system cancer, reproductive tract cancer, cancer related to HPV infection or cancer of the anus and genitals. Background technique [0002] Since the mid-1950s, preventive plans have been proposed for the most differing cancers. In many developed countries, screening programs for the entire population of cervical cancer have been established. However, similar screening programs can be used for other cancer entities and precursor stages such as urinary system cancer, respiratory tract, and other cancers. The following uses cervical cancer as an example to highlight the shortcomings of the current prevention plan. However, the fact is that the necessary modifications apply to other preventive programs for any cancer entity. [0003] Regarding cervical intraepithelial neoplasia and cervical gland da...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/574
CPCG01N33/57411G01N33/57484Y10T436/25
Inventor R·里德A·雷谢尔M·方克内贝尔德博奇M·赫克尔A·杜伟R·希普弗P·马丁
Owner ROCHE MTM LAB AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap